minimal Common Oncology Data Elements (mCODE) Implementation Guide, published by HL7 International / Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 4.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-mCODE-ig/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: rhabdomyosarcoma-clinical-group-stage-IA - XML Representation

Raw xml | Download

<Observation xmlns="http://hl7.org/fhir">
  <id value="rhabdomyosarcoma-clinical-group-stage-IA"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-stage"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Observation rhabdomyosarcoma-clinical-group-stage-IA</b></p><a name="rhabdomyosarcoma-clinical-group-stage-IA"> </a><a name="hcrhabdomyosarcoma-clinical-group-stage-IA"> </a><a name="rhabdomyosarcoma-clinical-group-stage-IA-en-US"> </a><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/observation-category laboratory}">Laboratory</span></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 405916000}">Intergroup rhabdomyosarcoma study post-surgical clinical group (observable entity)</span></p><p><b>subject</b>: <a href="Patient-cancer-patient-john-anyperson.html">John B. Anyperson  Male, DoB: 1951-01-20 ( Medical Record Number: m123 (use: usual, ))</a></p><p><b>focus</b>: <a href="Condition-primary-cancer-condition-nonspecific.html">Condition Metastatic malignant neoplasm (disorder)</a></p><p><b>effective</b>: 2021-04-01</p><p><b>performer</b>: <a href="Practitioner-us-core-practitioner-kyle-anydoc.html">Practitioner Kyle Anydoc </a></p><p><b>value</b>: <span title="Codes:{http://snomed.info/sct 405957007}">Intergroup rhabdomyosarcoma study post-surgical clinical group IA: localized tumor, confined to site of origin, completely resected (finding)</span></p></div>
  </text>
  <status value="final"/>
  <category>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/observation-category"/>
      <code value="laboratory"/>
    </coding>
  </category>
  <code>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="405916000"/>
      <display
               value="Intergroup rhabdomyosarcoma study post-surgical clinical group (observable entity)"/>
    </coding>
  </code>
  <subject>🔗 
    <reference value="Patient/cancer-patient-john-anyperson"/>
  </subject>
  <focus>🔗 
    <reference value="Condition/primary-cancer-condition-nonspecific"/>
  </focus>
  <effectiveDateTime value="2021-04-01"/>
  <performer>🔗 
    <reference value="Practitioner/us-core-practitioner-kyle-anydoc"/>
  </performer>
  <valueCodeableConcept>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="405957007"/>
      <display
               value="Intergroup rhabdomyosarcoma study post-surgical clinical group IA: localized tumor, confined to site of origin, completely resected (finding)"/>
    </coding>
  </valueCodeableConcept>
</Observation>